ATE358419T1 - Neue substituierte bernsteinsäure metall-beta- lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen - Google Patents

Neue substituierte bernsteinsäure metall-beta- lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen

Info

Publication number
ATE358419T1
ATE358419T1 AT00975454T AT00975454T ATE358419T1 AT E358419 T1 ATE358419 T1 AT E358419T1 AT 00975454 T AT00975454 T AT 00975454T AT 00975454 T AT00975454 T AT 00975454T AT E358419 T1 ATE358419 T1 AT E358419T1
Authority
AT
Austria
Prior art keywords
succinic acid
bacterial infections
substituted succinic
lactamase inhibitors
treatment
Prior art date
Application number
AT00975454T
Other languages
English (en)
Inventor
James M Balkovec
Mark L Greenlee
Steven H Olson
Gregory P Rouen
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of ATE358419T1 publication Critical patent/ATE358419T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/91Dibenzofurans; Hydrogenated dibenzofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/612Esters of carboxylic acids having a carboxyl group bound to an acyclic carbon atom and having a six-membered aromatic ring in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734Ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00975454T 1999-10-28 2000-10-27 Neue substituierte bernsteinsäure metall-beta- lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen ATE358419T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16237099P 1999-10-28 1999-10-28

Publications (1)

Publication Number Publication Date
ATE358419T1 true ATE358419T1 (de) 2007-04-15

Family

ID=22585340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00975454T ATE358419T1 (de) 1999-10-28 2000-10-27 Neue substituierte bernsteinsäure metall-beta- lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen

Country Status (9)

Country Link
US (3) US6630510B1 (de)
EP (1) EP1227721B1 (de)
JP (1) JP2003527332A (de)
AT (1) ATE358419T1 (de)
AU (1) AU771274B2 (de)
CA (1) CA2388076C (de)
DE (1) DE60034244T2 (de)
ES (1) ES2283327T3 (de)
WO (1) WO2001030148A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2408937A (en) * 2003-12-09 2005-06-15 Johnson & Johnson Medical Ltd pH dependent medicinal compositions
PL1748767T3 (pl) 2004-05-28 2012-08-31 Unigen Inc 1-(3-metylo-2,4-dimetoksyfenylo)-3-(2',4'-dihydroksyfenylo)-propan jako silny inhibitor tyrozynazy
PT1841432E (pt) * 2004-12-02 2010-10-25 Venus Remedies Ltd Composições para combater a resistência aos antibióticos mediada pela beta-lactamase usando inibidores da betalactamase úteis para injecção
CN101267815B (zh) 2005-09-22 2013-11-06 明治制果药业株式会社 金属-β-内酰胺酶抑制剂
JP5301272B2 (ja) * 2006-07-31 2013-09-25 Meiji Seikaファルマ株式会社 メタロ−β−ラクタマーゼ阻害剤
WO2009114921A1 (en) * 2008-03-17 2009-09-24 Dmitrienko Gary I INHIBITORS OF CLASS B AND CLASS D β-LACTAMASES
EP4046619A1 (de) 2008-07-21 2022-08-24 Unigen, Inc. Serie von hautaufhellenden (bleichenden) verbindungen
WO2010092446A1 (en) * 2009-01-19 2010-08-19 Orchid Chemicals & Pharmaceuticals Ltd Pharmaceutical composition comprising cilastatin, a chelating agent and opt. a penem antibiotic
US8586799B2 (en) 2011-03-24 2013-11-19 Unigen, Inc. Compounds and methods for preparation of diarylpropanes
GB201317619D0 (en) 2013-10-04 2013-11-20 Uni I Oslo Compounds
EP3261662B1 (de) * 2015-02-23 2021-07-21 Synthetic Biologics Inc. Carbapenemasen zur verwendung mit antibiotika zum schutz des intestinalen mikrobioms
GB201613946D0 (en) 2016-08-15 2016-09-28 Univ Oslo Compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63208596A (ja) * 1986-11-05 1988-08-30 メルク エンド カムパニー インコーポレーテツド 新規な抗菌剤およびカルバペネム抗生物質の効力増強剤
US4770799A (en) 1987-01-02 1988-09-13 Mobil Oil Corporation Copper salts of hindered phenol substituted succinic anhydride derivatives as antioxidant additives
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
US5414108A (en) * 1992-08-11 1995-05-09 Biogal Gyogyszergrar Process for the preparation of carboxylic acids and derivatives of them
US5559088A (en) * 1995-07-07 1996-09-24 The Proctor & Gamble Company Dryer-activated fabric conditioning and antistatic compositions with improved perfume longevity
AU7084996A (en) 1995-09-15 1997-04-01 Smithkline Beecham Plc Pyrrolidine and thiazole derivatives with antibacterial and metallo-beta-lactamase inhibitory properties
GB9524267D0 (en) 1995-11-28 1996-01-31 Isis Innovation Enzyme inhibitor and method
AU1766997A (en) 1996-02-13 1997-09-02 Smithkline Beecham Plc Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
CA2268930A1 (en) 1996-10-17 1998-04-30 Smithkline Beecham P.L.C. Beta-thiopropionyl-amino acid derivatives and their use as beta-lactamase inhibitors
GB9704522D0 (en) 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
EP0970062A2 (de) 1997-03-13 2000-01-12 Smithkline Beecham Plc Pyrrolidin- und thiazolderivate mit metallo-beta-lactamasehemmenden eigenschaften
GB9705682D0 (en) * 1997-03-19 1997-05-07 Unilever Plc Cleaning composition comprising fluoro-surfactants

Also Published As

Publication number Publication date
US6630510B1 (en) 2003-10-07
US20030078418A1 (en) 2003-04-24
US20030207859A1 (en) 2003-11-06
JP2003527332A (ja) 2003-09-16
EP1227721A1 (de) 2002-08-07
DE60034244D1 (de) 2007-05-16
WO2001030148A1 (en) 2001-05-03
AU771274B2 (en) 2004-03-18
EP1227721B1 (de) 2007-04-04
DE60034244T2 (de) 2007-12-20
AU1350401A (en) 2001-05-08
CA2388076C (en) 2008-07-22
EP1227721A4 (de) 2004-09-22
ES2283327T3 (es) 2007-11-01
CA2388076A1 (en) 2001-05-03

Similar Documents

Publication Publication Date Title
MY138797A (en) Bacterial gyrase inhibitors and uses thereof
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
ATE358419T1 (de) Neue substituierte bernsteinsäure metall-beta- lactamase-inhibitoren und ihre verwendung zur behandlung von bakteriellen infektionen
MY122353A (en) 13-membered azalides and their use as antibiotic agents
AP2001002131A0 (en) Novel macrolide antibiotics.
DE69917717D1 (de) C11-Carbamate von antibakteriellen Makroliden
PT1132392E (pt) Antibioticos cetolidos
RU94030236A (ru) Производные 3 бета-алкенил-пенама, способ их получения, лекарственные средства и их применение для борьбы и предупреждения болезней
ATE339424T1 (de) 3-substituierte 7-alkylidene-3-cephem-4- carbonsäuren als beta-lactamase inhibitoren
ES2178301T3 (es) Derivados del acido penicilanico 2-beta-sustituido-6-alquilideno como inhibidores de la beta-lactama.
MA27257A1 (fr) Composes utiles pour le traitement du charbon et l'inhibition du gene letal
ATE165101T1 (de) Basische prolinamid derivate von ge2270 und ge2270-ahnlichten antibiotika
CY1107038T1 (el) Μεθοδος θεραπειας βακτηριακων λοιμωξεων με χρηση της γεμιφλοξασινης ή ενος αλατος αυτης και ενος αντιβιοτικου β-λακταμης
PT1167376E (pt) Antibioticos macrolidos
EA200500398A1 (ru) ПРОЛЕКАРСТВО ИНГИБИТОРА β-ЛАКТАМАЗЫ
ATE330960T1 (de) Beta-lactamase hemmende verbindungen
AU2002362008A1 (en) Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
EP0911030A3 (de) Antimikrobielle Zusammensetzungen welche Vinylpyrrolidinon-Cephalosporin-Derivate und ein Carbapenemantibiotikum oder ein beta-lactamaseinhibitor enthaten
MXPA05012895A (es) Profarmaco inhibidor de beta-lactamasa.
ES2114476A1 (es) Nuevas penicilinas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties